PTC Therapeutics
PTCT
#2605
Rank
HK$54.19 B
Marketcap
HK$653.36
Share price
2.41%
Change (1 day)
73.47%
Change (1 year)

Market capitalization of PTC Therapeutics (PTCT)

Market cap: HK$54.19 Billion

As of July 2026 PTC Therapeutics has a market cap of HK$54.19 Billion. This makes PTC Therapeutics the world's 2605th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of PTC Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$54.19 B10.43%
2025HK$49.07 B81.21%
2024HK$27.08 B66.73%
2023HK$16.24 B-25.37%
2022HK$21.76 B-0.88%
2021HK$21.95 B-31.99%
2020HK$32.28 B39.35%
2019HK$23.16 B70.34%
2018HK$13.60 B151.54%
2017HK$5.40 B86.23%
2016HK$2.90 B-65.91%
2015HK$8.51 B-35.53%
2014HK$13.21 B321.75%
2013HK$3.13 B

End of Day market cap according to different sources

On Jul 5th, 2026 the market cap of PTC Therapeutics was reported to be:

HK$54.19 Billion
by Nasdaq info icon info icon
HK$54.19 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
HK$2.392 T 4,315.07%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
HK$1.051 T 1,839.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
HK$8.72 B-83.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$15.96 B-70.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
HK$2.66 B-95.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
HK$88.22 B 62.78%๐Ÿ‡บ๐Ÿ‡ธ USA